If you would like to submit a proposal for an oral or poster presentation at this
meeting, please click the 'submit abstract' button to view the information required
for your submission.
When ready just return to this page and fill out the form accordingly.
All abstracts will be reviewed by the Scientific Advisory Board and applicants will
be notified of the result in due course.
Successful applicants will be provided with all necessary information.
Abstract Content:
- Written in English
- Written in the third person
- Include title, name(s) and affiliation(s) of the authors
- Between 100 - 200 words
- Suitable for direct publication in the proceedings pack and on the website
- Related to the subject of the conference
Agenda Topics- Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development
- Companion Diagnostics in Various Disease Classes
- Epigenetic Modifications (Hypermethylation of specific genes) as Biomarkers for Diagnostics
- Next-Generation Sequencing (NGS) for Liquid Biopsy Development and Companion Diagnostics
- Protein Biomarkers versus Nucleic Acid Biomarkers for Companion Diagnostics Development
- Therapeutic Potential: Automimmune Diseases, Cancer, Cardiovascular Disease, CNS and Neurodegenerative Diseases and Traumatic Brain Injury, Pregnancy and Reproductive Health
- Circulating DNA, Circulating RNA, Circulating Tumor Cells, Circulating Proteins
- Circulating Biomarker Classes: Exosomes, Microvesicles, Circulating-Free DNA (cfDNA), Circulating RNA, Circulating Tumor Cells
- Circulating microRNAs
- Circulating Protein Biomarkers
- Circulating Transcriptome
- Circulating-Free (cfDNA) in various Cancer Classes
- Circulating-Free DNA
- Next-Generation Sequencing (NGS), Digital PCR and qPCR Development for analysis of cf-DNA
- Exosomes and Microvesicles
- Extracellular Vesicle-based Biomarkers: Exosomes and Microvesicles in Biological Fluids
- Extracellular Vesicles as Biomarker Carriers in Various Disease Classes
- Research Methodologies and Workflow: Isolation, Capture, Biomarker Cargo Analysis
- Various Subclasses of Extracellular Vesicles (EVs) and their Biomarker Cargo: Exosomes, Microvesicles, Oncosomes
- Technology & Company Showcase, Commercialization & the Regulatory Landscape
- Asia/Pacific vs EU vs US Regulatory Landscape and Barriers to Entry
- Company Case Studies
- Emerging Technology Showcase: Companies Highlight Products and Services in the Liquid Biopsy Space
- Transforming your IPs into clinically validated Diagnostic Devices
- Why Singapore?
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility
of the content of the abstract and we assume that all co-authors are aware of this
content. Please note that your biography, summary and abstract may be used on this
website and conference materials.
|
